Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tiziana Life Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 10
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Tiziana Life Sciences Acquires Bio-Repository from Shardna for USD0.3 Million 12
Licensing Agreements 13
Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Women’s Hospital 13
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune 14
Tiziana Life Sciences Enters into Agreement with Cardiff University 15
Tiziana Life Sciences Enters into Licensing Agreement with Nerviano Medical Sciences for Milciclib 16
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune for Foralumab 18
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 19
Equity Offering 20
Tiziana Life Sciences to Raise USD10 Million in Public Offering of ADS 20
Tiziana Life Sciences Raises USD0.8 Million in Private Placement of Shares 21
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares 22
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares and Warrants 23
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares 24
Tiziana Life Sciences Raises USD0.4 Million in Private Placement of Shares 25
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares 26
Tiziana Life Sciences Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 27
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 28
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares upon Exercise of Warrants 29
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 30
Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 31
Tiziana Life Sciences Completes Placement for USD3.3 Million 32
Acquisition 33
Alexander David Investments Completes Acquisition of Tiziana Pharma in Reverse Takeover Transaction 33
Tiziana Life Sciences Plc – Key Competitors 34
Tiziana Life Sciences Plc – Key Employees 35
Tiziana Life Sciences Plc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Sep 24, 2018: Tiziana Life Sciences: Interim Results for the Six Months Ended 30 June 2018 37
Jun 07, 2018: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2017 39
Sep 29, 2017: Tiziana Life Sciences: Interim Results for the Six Months Ended 30 June 2017 46
May 23, 2017: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2016 52
Corporate Communications 53
Jun 12, 2017: Tiziana Life Sciences Strengthens Unique Research Focus by Appointing Dr Kunwar Shailubhai as Chief Executive Officer 53
Mar 14, 2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 55
Product News 56
07/28/2017: Publication of Research Article on Foralumab, a Fully Human Anti-CD3 Antibody Being Developed as an Oral Therapy for NASH and Autoimmune Diseases 56
03/14/2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 57
Clinical Trials 58
Dec 08, 2017: Tiziana Life Sciences Announces Safety of Milciclib in a Phase 2a Trial in Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Patients 58
Nov 23, 2017: Tiziana Life Sciences Announces that Milciclib Met its Primary Endpoint in Two Phase II Clinical Trials in Patients with Thymic Carcinoma and Thymoma” 59
Sep 06, 2017: Development of a Proprietary Oral Formulation of Foralumab, a Fully Human Anti-CD3 mAb, for use in an Upcoming Phase 2a Clinical Trial in NASH 61
Jul 19, 2017: Tiziana Life Sciences Announces Initiation of a Phase IIa Clinical Trial with Milciclib in Patients with Hepatocellular Carcinoma 62
Apr 24, 2017: Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib in Patients with Hepatocellular Carcinoma 63
Apr 21, 2017: Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tiziana Life Sciences Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Tiziana Life Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 10
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Tiziana Life Sciences Acquires Bio-Repository from Shardna for USD0.3 Million 12
Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Women's Hospital 13
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune 14
Tiziana Life Sciences Enters into Agreement with Cardiff University 15
Tiziana Life Sciences Enters into Licensing Agreement with Nerviano Medical Sciences for Milciclib 16
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune for Foralumab 18
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 19
Tiziana Life Sciences to Raise USD10 Million in Public Offering of ADS 20
Tiziana Life Sciences Raises USD0.8 Million in Private Placement of Shares 21
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares 22
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares and Warrants 23
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares 24
Tiziana Life Sciences Raises USD0.4 Million in Private Placement of Shares 25
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares 26
Tiziana Life Sciences Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 27
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 28
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares upon Exercise of Warrants 29
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 30
Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 31
Tiziana Life Sciences Completes Placement for USD3.3 Million 32
Alexander David Investments Completes Acquisition of Tiziana Pharma in Reverse Takeover Transaction 33
Tiziana Life Sciences Plc, Key Competitors 34
Tiziana Life Sciences Plc, Key Employees 35
Tiziana Life Sciences Plc, Other Locations 36
Tiziana Life Sciences Plc, Subsidiaries 36
List of Figures
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tiziana Life Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 10